Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7807438 Preparation of purified exosomes comprising HCV RNA

Patent 7807438 was granted and assigned to Novartis on October, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Piero Pileri0

Sergio Abrignani0

Date of Patent

October 5, 2010

Patent Application Number

11699925

Date Filed

January 30, 2007

Patent Citations Received

US Patent 11959922 Macromolecule analysis employing nucleic acid encoding

0

US Patent 11782062 Kits for analysis using nucleic acid encoding and/or label

US Patent 12019077 Macromolecule analysis employing nucleic acid encoding

0

US Patent 12130291 Kits for analysis using nucleic acid encoding and/or label

0

US Patent 12123878 Macromolecule analysis employing nucleic acid encoding

0

US Patent 12019078 Macromolecule analysis employing nucleic acid encoding

0

Patent Primary Examiner

Zachariah Lucas

Patent abstract

The invention relates to a method for isolation of hepatitis C virus. The method comprises the separation of particles termed exosomes from the blood plasma of an individual infected with hepatitis C virus (HCV) and the extraction or RNA from these exosome particles.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7807438 Preparation of purified exosomes comprising HCV RNA

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool